TW Kim, JH Lee, L He, DA Boyd, CF Hung, TC Wu. (2005) " DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimen. " Hum Gene Ther 16. 26-34 PMID: 15703486 DOI: 10.1089/hum.2005.16.26 | Abstract and Keywords
R Chavan, KA Marfatia, IC An, DA Garber, MB Feinberg. (2006) " Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses. " J Virol 80. 7676-87 PMID: 16840346 DOI: 10.1128/JVI.02748-05 | Abstract and Keywords
M Chakraborty, J Schlom, JW Hodge. (2007) " The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses. " Cancer Immunol Immunother 56. 1471-84 PMID: 17318654 DOI: 10.1007/s00262-007-0291-6 | Abstract and Keywords
J Liu, M Hellerstein, M McDonnel, RR Amara, LS Wyatt, B Moss, HL Robinson. (2007) " Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. " Vaccine 25. 2951-8 PMID: 17360078 DOI: 10.1016/j.vaccine.2006.05.081 | Abstract and Keywords
PL Earl, JL Americo, LS Wyatt, LA Eller, DC Montefiori, R Byrum, M Piatak, JD Lifson, RR Amara, HL Robinson, JW Huggins, B Moss. (2007) " Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate. " Virology 366. 84-97 PMID: 17499326 DOI: 10.1016/j.virol.2007.02.041 | Abstract and Keywords